Format

Send to

Choose Destination
Clin Interv Aging. 2006;1(3):247-51.

Citicoline (Cognizin) in the treatment of cognitive impairment.

Author information

1
Department of Psychiatric Science and Psychological Medicine, University of Rome La Sapienza, Rome, Italy. mario.fioravanti@uniromaI.it

Abstract

Pharmacological treatment of cerebrovascular disorders was introduced at the beginning of the 20th Century. Since then, a multitude of studies have focused on the development of a consensus for a well defined taxonomy of these disorders and on the identification of specific patterns of cognitive deficits associated with them, but with no clear consensus. Nevertheless, citicoline has proved to be a valid treatment in patients with a cerebrovascular pathogenesis for memory disorders. A metanalysis performed on the entire database available from the clinical studies performed with this compound confirms the experimental evidence from the animal studies which have repeatedly described the multiple biological actions of citicoline in restoring both the cell lipid structures and some neurotransmitter functions.

PMID:
18046877
PMCID:
PMC2695184
DOI:
10.2147/ciia.2006.1.3.247
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center